A detailed history of D.A. Davidson & Co. transactions in Organon & Co. stock. As of the latest transaction made, D.A. Davidson & Co. holds 122,147 shares of OGN stock, worth $1.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
122,147
Previous 120,618 1.27%
Holding current value
$1.8 Million
Previous $2.5 Million 6.41%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.65 - $23.03 $28,515 - $35,212
1,529 Added 1.27%
122,147 $2.34 Million
Q2 2024

Jul 31, 2024

BUY
$17.45 - $21.96 $52,960 - $66,648
3,035 Added 2.58%
120,618 $2.5 Million
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $995,191 - $1.36 Million
72,220 Added 159.2%
117,583 $2.21 Million
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $1,970 - $3,117
180 Added 0.4%
45,363 $654,000
Q3 2023

Nov 08, 2023

SELL
$16.59 - $23.77 $3,168 - $4,540
-191 Reduced 0.42%
45,183 $784,000
Q2 2023

Aug 10, 2023

SELL
$19.27 - $24.63 $15,184 - $19,408
-788 Reduced 1.71%
45,374 $944,000
Q1 2023

Apr 25, 2023

SELL
$21.42 - $32.08 $74,948 - $112,247
-3,499 Reduced 7.05%
46,162 $1.09 Million
Q4 2022

Feb 03, 2023

SELL
$23.31 - $28.61 $80,675 - $99,019
-3,461 Reduced 6.52%
49,661 $1.39 Million
Q3 2022

Nov 07, 2022

SELL
$23.4 - $34.25 $798,946 - $1.17 Million
-34,143 Reduced 39.13%
53,122 $1.25 Million
Q2 2022

Jul 28, 2022

SELL
$31.66 - $38.9 $108,435 - $133,232
-3,425 Reduced 3.78%
87,265 $2.95 Million
Q1 2022

May 12, 2022

BUY
$30.45 - $39.36 $1.12 Million - $1.44 Million
36,687 Added 67.94%
90,690 $3.17 Million
Q4 2021

Jan 31, 2022

BUY
$28.67 - $37.13 $28,956 - $37,501
1,010 Added 1.91%
54,003 $1.65 Million
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $75,440 - $93,911
2,635 Added 5.23%
52,993 $1.74 Million
Q2 2021

Aug 10, 2021

BUY
$28.45 - $38.0 $1.43 Million - $1.91 Million
50,358 New
50,358 $1.52 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.